Predictors and clinical relevance of hemorrhagic transformation after endovascular therapy for anterior circulation large vessel occlusion strokes: a multicenter retrospective analysis of 1122 patients
暂无分享,去创建一个
A. Rai | A. Yoo | D. Liebeskind | R. Nogueira | J. Hirsch | E. Levy | T. Jovin | O. Zaidat | S. Natarajan | Rishi Gupta | M. Rymer | R. Lin | Michael Chen | Thanh N. Nguyen | A. Abou-Chebl | A. Nanda | A. Tayal | J. Kalia | D. Hsu | Q. Hao | M. Tian | A. Abou‐Chebl
[1] Eric E. Smith,et al. Risk Score for Intracranial Hemorrhage in Patients With Acute Ischemic Stroke Treated With Intravenous Tissue-Type Plasminogen Activator , 2012, Stroke.
[2] L. Schwamm,et al. Safety of full-dose intravenous recombinant tissue plasminogen activator followed by multimodal endovascular therapy for acute ischemic stroke , 2012, Journal of NeuroInterventional Surgery.
[3] Gary A. Ford,et al. Predicting the Risk of Symptomatic Intracerebral Hemorrhage in Ischemic Stroke Treated With Intravenous Alteplase: Safe Implementation of Treatments in Stroke (SITS) Symptomatic Intracerebral Hemorrhage Risk Score , 2012, Stroke.
[4] M. Kaste,et al. Symptomatic intracranial hemorrhage after stroke thrombolysis: The SEDAN Score , 2012, Annals of neurology.
[5] A. Rabinstein,et al. Symptomatic Intracranial Hemorrhage following Intravenous Thrombolysis for Acute Ischemic Stroke: A Critical Review of Case Definitions , 2012, Cerebrovascular Diseases.
[6] W. Hacke,et al. Improved Prediction of Poor Outcome After Thrombolysis Using Conservative Definitions of Symptomatic Hemorrhage , 2012, Stroke.
[7] M. Kaste,et al. Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis , 2011, Neurology.
[8] A. Yoo,et al. Prediction of adverse outcomes by blood glucose level after endovascular therapy for acute ischemic stroke. , 2011, Journal of neurosurgery.
[9] G. Gravlee. Conscious Sedation Versus General Anesthesia During Endovascular Therapy for Acute Anterior Circulation Stroke: Preliminary Results From a Retrospective, Multicenter Study , 2011 .
[10] Chad M. Miller,et al. Predictors of Subarachnoid Hemorrhage in Acute Ischemic Stroke With Endovascular Therapy , 2010, Stroke.
[11] D. Leys,et al. Asymptomatic Hemorrhagic Transformation of Infarction and Its Relationship With Functional Outcome and Stroke Subtype: Assessment From the Tinzaparin in Acute Ischaemic Stroke Trial , 2010, Stroke.
[12] T. Jovin,et al. Endovascular treatment of carotid embolic occlusions has a higher recanalization rate compared with cardioembolic occlusions , 2009, Journal of NeuroInterventional Surgery.
[13] Gary A. Ford,et al. Multivariable Analysis of Outcome Predictors and Adjustment of Main Outcome Results to Baseline Data Profile in Randomized Controlled Trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST) , 2008, Stroke.
[14] Keith Muir,et al. Thrombolysis with alteplase 3–4·5 h after acute ischaemic stroke (SITS-ISTR): an observational study , 2008, The Lancet.
[15] M. Kaste,et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. , 2008, The New England journal of medicine.
[16] H. Lutsep,et al. Mechanical Thrombectomy for Acute Ischemic Stroke: Final Results of the Multi MERCI Trial , 2008, Stroke.
[17] L. Wechsler,et al. Factors Predicting Hemorrhagic Complications after Multimodal Reperfusion Therapy for Acute Ischemic Stroke , 2007, American Journal of Neuroradiology.
[18] G. Albers,et al. Symptomatic Intracerebral Hemorrhage following Thrombolytic Therapy for Acute Ischemic Stroke: A Review of the Risk Factors , 2007, Cerebrovascular Diseases.
[19] J. Broderick,et al. Intracranial Hemorrhage Associated With Revascularization Therapies , 2007, Stroke.
[20] A. Demchuk,et al. Asymptomatic Hemorrhage After Thrombolysis May Not Be Benign: Prognosis by Hemorrhage Type in the Canadian Alteplase for Stroke Effectiveness Study Registry , 2007, Stroke.
[21] Ims Study Investigators. Hemorrhage in the Interventional Management of Stroke Study , 2006, Stroke.
[22] J. Grotta,et al. Asymptomatic hemorrhagic transformation of cerebral infarction does not worsen long-term outcome. , 2005, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[23] Eng H. Lo,et al. The Neurotoxicity of Tissue Plasminogen Activator? , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[24] J. Mohr. Endovascular therapy. , 2019, Cerebrovascular diseases.
[25] J. Arenillas,et al. Thrombolysis-Related Hemorrhagic Infarction: A Marker of Early Reperfusion, Reduced Infarct Size, and Improved Outcome in Patients With Proximal Middle Cerebral Artery Occlusion , 2002, Stroke.
[26] L Bozzao,et al. Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. , 1999, Stroke.